Arcturus Therapeutics (ARCT) Misses Q3 EPS by 46c

Arcturus Therapeutics (NASDAQ: ARCT) reported Q3 EPS of ($2.05), $0.46 worse than the analyst estimate of ($1.59).

For earnings history and earnings-related data on Arcturus Therapeutics (ARCT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• AeroVironment restates quarterly financials, citing $89M goodwill error